Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Odejide received her medical degree from Howard University. She completed postgraduate training in Internal Medicine at the Brigham and Women's Hospital, followed by a fellowship training in Hematology and Medical Oncology at the Dana-Farber/Partners CancerCare Program. She is currently a member of the DFCI Hematologic Malignancies staff as well as a member of the Division of Population Sciences.
Oreofe Odejide, MD, MPH, discusses her work and patient care at the Lymphoma program. She treats patients with non-Hodgkin lymphoma, Hodgkin lymphoma, and chronic lymphocytic leukemia (CLL). As lymphoma has over 40 subtypes, Odejide believes that it’s important for patients to understand their diseases, and encourages them to bring their questions to her. Learn more about the Adult Lymphoma program: http://www.dana-farber.org/lymphoma-program/
Outcomes Research, Health Services Research, Hematologic Malignancies
The focus of my research is to understand patterns of care, comparative effectiveness of treatments, and quality of care for patients with hematologic malignancies, throughout the continuum of disease from diagnosis through the end of life (EOL). I am interested in developing targeted interventions to improve the quality of care for patients with hematologic malignancies.
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions